This is not the most recent version of the article. View current version (3 AUG 2014)
Aspirin as adjunctive treatment for giant cell arteritis
Editorial Group: Cochrane Eyes and Vision Group
Published Online: 30 APR 2013
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Mollan SP, Marrone M, Burdon MA, Levin LA, Denniston AK. Aspirin as adjunctive treatment for giant cell arteritis (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD010453. DOI: 10.1002/14651858.CD010453.
- Publication Status: New
- Published Online: 30 APR 2013
This is not the most recent version of the article. View current version (03 AUG 2014)
This is the protocol for a review and there is no abstract. The objectives are as follows:
- To perform a systematic review of best-available evidence regarding the use of low dose aspirin, as an adjunctive, in the treatment of giant cell arteritis (GCA).
- To investigate the efficacy of aspirin in reducing morbidity and mortality in GCA.
- To document the incidence of adverse effects related to aspirin use in GCA.